Clinical Trial Update: Immunosafe-CeD: Are Partially Hydrolysed Gluten Harmful to Celiac Disease Patients? [NA]

View source ↗

Summary

A completed clinical trial evaluating whether partially hydrolysed gluten is harmful in people with celiac disease, sponsored by Oslo University Hospital.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Celiac Disease

Drugs mentioned

• Immunosafe-CeD

Snippet

Sponsor: Oslo University Hospital | Conditions: Celiac Disease, Food Intolerance | NA | Status: COMPLETED